Zacks.com on MSN9h
Curious about TransMedics (TMDX) Q4 Performance? Explore Wall Street Estimates for Key MetricsBeyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on TransMedics Group (TMDX – Research Report), with a ...
Van ECK Associates Corp grew its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 102.3% in the fourth ...
Hosted on MSN4m
Artivion (AORT) Reports Break-Even Earnings for Q4Artivion (AORT) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.12. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for ...
Media are invited to join Marc G. Serré, Member of Parliament for Nickel Belt, alongside Douglas Gervais, Mayor of Espanola for the ...
NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman
The complaint alleges that TransMedics made false and misleading statements, while failing to disclose crucial information. Specifically, the suit contends that TransMedics used kickbacks ...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback